Odyssey Therapeutics, Inc. (NASDAQ:ODTX) Receives Average Recommendation of “Buy” from Analysts

Shares of Odyssey Therapeutics, Inc. (NASDAQ:ODTX) have received an average rating of “Buy” from the five research firms that are currently covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $32.00.

A number of brokerages have weighed in on ODTX. Cantor Fitzgerald began coverage on shares of Odyssey Therapeutics in a research note on Tuesday. They issued an “overweight” rating on the stock. Wall Street Zen upgraded shares of Odyssey Therapeutics to a “hold” rating in a report on Saturday, May 16th. Oppenheimer assumed coverage on Odyssey Therapeutics in a report on Tuesday. They set an “outperform” rating and a $40.00 price objective for the company. TD Cowen assumed coverage on Odyssey Therapeutics in a research note on Tuesday. They issued a “buy” rating on the stock. Finally, JPMorgan Chase & Co. started coverage on Odyssey Therapeutics in a research report on Tuesday. They set an “overweight” rating and a $26.00 price target for the company.

Odyssey Therapeutics Trading Down 0.3%

Shares of ODTX traded down $0.05 on Tuesday, hitting $16.96. The company’s stock had a trading volume of 127,382 shares, compared to its average volume of 330,139. Odyssey Therapeutics has a fifty-two week low of $15.35 and a fifty-two week high of $20.30.

Insider Buying and Selling at Odyssey Therapeutics

In other Odyssey Therapeutics news, major shareholder Tpg Gp A, Llc bought 1,388,889 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was acquired at an average price of $18.00 per share, with a total value of $25,000,002.00. Following the completion of the transaction, the insider owned 3,690,146 shares in the company, valued at approximately $66,422,628. This trade represents a 60.35% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Sr One Capital Management, Llc purchased 555,555 shares of the stock in a transaction on Monday, May 11th. The stock was acquired at an average price of $18.00 per share, for a total transaction of $9,999,990.00. Following the completion of the purchase, the insider directly owned 1,831,383 shares in the company, valued at approximately $32,964,894. The trade was a 43.54% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 4,183,777 shares of company stock valued at $75,319,986 in the last three months.